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Materials and Methods:
A motion phantom (Quasar respiratory phantom, Modus Medical Devices) was used to simulate sinusoidal motion with peak-to-peak 'breathing' amplitude of 2cm and different frequencies (12 and 20 breaths/min), synchronized with Real-Time Positional Management (RPM) System (Varian Medical System, Palo Alto CA). Dose evaluations regarding static, ungated and gated delivery were carried out using EBT2 films. For all treatments a 6MV photon beam was used and 3Gy were prescribed and delivered to the isocenter. For conventional treatments we acquired dose profiles in motion direction for different gating windows. The profiles were compared to those obtained with the stationary phantom delivery in terms of displacements of therapeutic dose levels (95% prescribed dose) and low dose levels (20% prescribed dose). 3DCRT and IMRT treatments were performed in static, ungated and gated mode (40%-70% phase at exhale) whereas VMAT was performed only in static and ungated mode, because this treatment technique is not managed by the accelerator Varian's Clinac DHX. Measured dose distributions in 3DCRT, IMRT and VMAT treatments were compared to those planned using the gamma index with 3mm distance-to-agreement and 5% dosedifference criteria. Results: As regards conventional treatment, ungated profiles displacements at the 95% and 20% dose levels were 12mm and 15mm respectively. Gated profiles showed an asymmetric enlargement according to target position with respect to the gating window: range shifts at the 95% and 20% dose levels were from 4 to 29mm and from 8.5 to 25.6mm respectively. In static dose distributions the percentage of points passing the gamma criteria, for all treatments, was 92%. The dynamic measurements showed a gamma agreement of 30-33% for all ungated treatments and of 70-74% for gated 3DCRT and IMRT delivery. Respiratory motion resulted in significant dose blurring, which led to an enlarged beam penumbra at the field edge and thereby underdosing of the target and overdosing of surrounding areas. This effect was reduced by gated delivery although dose distribution enlargement was still observed due to the residual motion inside the gating windows.
Conclusions:
The profile analysis in the conventional treatment suggests that dose blurring could be reduced by applying asymmetric expansion margins to the CTV according to gating window. Experimental evidence suggests that, if a significant organ motion is involved and a respiratory management system is not used, modulated intensity techniques should be avoided, because planned dose distribution is not longer representative of delivered dose.
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Evaluation of setup errors in a randomised study using CBCT & kVkV imaging for prostate radiotherapy C. Purpose/Objective: Prospective assessment of setup errors using 3D cone-beam CT (CBCT) and stereoscopic kV imaging using fiducial markers for image registration. Materials and Methods: 23 patients underwent prostate ± seminal vesicle radiotherapy with 3 fiducial markers (1/23 had 5 markers). Each patient was randomised to start treatment on one of 2 linacs with different imaging systems, one with OBI (linac 1), the other with ExacTrac (linac 2), and then alternate weekly. Only OBI imaging is considered here. Prior to each fraction on linac 1, a CBCT was acquired, followed immediately by a pair of orthogonal stereoscopic kV images (kV/kV) using Varian OBI (v1.4 & 1.5). kV images were automatically matched online using marker match software (including couch/yaw rotation), and translations applied prior to treatment. 318 of 375 CBCTs acquired were available to match, and were matched offline -first to stable pelvic bony anatomy (for couch/yaw rotation) and then manually to an average position of all markers for the translations. Setup results were compared between CBCT and kV image matches in each orthogonal direction. The imaging methods were considered equivalent if the difference between setup errors were <2mm in each direction in 90% of cases. To aid comparison, patient population systematic and random errors were also calculated, and imaging isocentre coincidence (with mechanical linac isocentre) was obtained from analysis of regular QA results. Results: 207 of 318 fractions (65%) gave a difference in setup error <2mm in all directions. Average difference (CBCT -kV/kV) was 0.3mm. Population systematic and random errors, and imaging isocentre accuracy are shown in table 1. left/right (L/R), superior/inferior (S/I) and anterior/posterior (A/P). Conclusions: 35% of fractions showed setup error differences ≥2mm between orthogonal kV and CBCT that could be due to the subjective nature of the manual CBCT matching, and may be affected by the different matching methods used for couch rotation. In terms of isocentre accuracy and patient population random and systematic errors, CBCT and orthogonal kV modes showed similar results. If the same method for matching CBCTs offline can be performed online, this gives the flexibility to choose between setup using CBCT or orthogonal kV imaging without losing setup accuracy -depending on preference of gaining additional soft tissue information or faster setup with lower imaging dose.
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Gated Rapidarc using KV intrafraction verification for liver stereotactic treatment L. Bedos Purpose/Objective: We report the results of motion management during gated rapidarc treatment using implanted fiducial markers and a novel application, Intrafraction Motion Review (IMR, Varian medical systems) allowing simultaneous KV/MV utilization. Materials and Methods: Eight liver cancer patients with implanted fiducial markers were treated using the gated RapidArc technique with a Varian Novalis Truebeam linear accelerator. The fiducial markers (1 to 3) were implanted inside or close to the tumor target before treatment simulation. For patient simulation, three to four 4D computed tomography (CT) scans were acquired using Real time Position management (RPM) system to study the reproducibility of liver motion. During the treatment planning, the internal target volume (ITV) was outlined. The PTV was created by adding a 5 mm margin from the ITV. In the same stage, the fiducial were marked in
